Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitie Share News (MTO)

Share Price Information for Mitie (MTO)

Share Price is delayed by 15 minutes
Get Live Data
165.00    -5.20 (-3.06%)
Bid:
164.90
Ask:
165.10
Spread: 0.20 (0.121%)
Market Cap: £2.07b
MTO Live PriceLast checked at - London Stock Exchange

Intraday Mitie Share Chart

Thursday broker round-up

Thu, 13th Oct 2016 13:43
(ShareCast News) - Ted Baker: Goldman Sachs keeps at buy with a target price of 3140p.Brown N: HSBC reiterates hold, 205p target.MITIE: Citigroup keeps at neutral with a 280p target.Prudential: Societe Generale reiterates outperform with a 1250p target.Astrazeneca: Jefferies keeps at buy with a 6000p target.Kier Group: JP Morgan keeps at overweight with a target price of 1570p.United Utilities: Societe Generale upgrades to buy sell with a target price of 1040p.Game Digital: Canaccord stays at hold with a 72p target.Tate & Lyle: JP Morgan reiterates neutral with a target of 770p.GlaxoSmithKline: Jefferies maintains buy with a 1950p target.DFS: Jefferies keeps at buy with a 280p target.Inmarsat: JP Morgan reiterates overweight with a 950p target.

Related News

Ingredion in talks to buy UK's Tate & Lyle for $3.6 billion, Bloomberg News reports
9 hours ago

Ingredion in talks to buy UK's Tate & Lyle for $3.6 billion, Bloomberg News reports

June 7 (Reuters) - ​U.S. food ingredients maker Ingredion is in advanced talks to ​acquire ‌Britain's Tate & Lyle in a deal valued at £2.7 billion...

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris
11 hours ago

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris

(Alliance News) - AstraZeneca PLC on Saturday announced new data on its kidney disease treatment Ultomiris.

PRESS: AstraZeneca warns it could delay Europe drug launches - FT
1 day ago

PRESS: AstraZeneca warns it could delay Europe drug launches - FT

(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, C...

Mitie News

LONDON BROKER RATINGS: Jefferies raises CMC; RBC cuts discoverIE
2 days ago

LONDON BROKER RATINGS: Jefferies raises CMC; RBC cuts discoverIE

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

WINNERS & LOSERS: CMC jumps on earnings; financial stocks retreat
3 days ago

WINNERS & LOSERS: CMC jumps on earnings; financial stocks retreat

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.

Mitie raises payout though annual profit slips on exceptional costs
3 days ago

Mitie raises payout though annual profit slips on exceptional costs

(Alliance News) - Mitie Group PLC on Thursday posted lower profit in financial 2026, partly due to exceptional costs, but nonetheless hiked its shareh...

LONDON BRIEFING: CMC profit jumps; Hg increases investment in HgT
3 days ago

LONDON BRIEFING: CMC profit jumps; Hg increases investment in HgT

(Alliance News) - CMC Markets reports higher annual profit and lifts its dividend, Hg plans to increase its stake in HgCapital Trust, and S4 Capital u...

Mitie upbeat after jump in annual earnings
3 days ago

Mitie upbeat after jump in annual earnings

(Sharecast News) - Mitie Group said on Thursday that it had started the current year on the front foot, after posting a jump in annual earnings.

LONDON BROKER RATINGS: Morgan Stanley raises ITM; Goldman likes Ceres
29 Apr 2026

LONDON BROKER RATINGS: Morgan Stanley raises ITM; Goldman likes Ceres

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

LONDON BROKER RATINGS: Exane BNP initiates coverage; UBS cuts SSP
28 Apr 2026

LONDON BROKER RATINGS: Exane BNP initiates coverage; UBS cuts SSP

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: